
Dialogue Health Technologies Inc.
DLHTFOTCHealthcare
$3.79
+$0.02(+0.59%)
Market Cap$254797554
P/E Ratio—
52W High$3.7922
52W Low$2.07
Dialogue Health Technologies Inc. (DLHTF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DLHTF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $87.13M | $68.05M | $35.80M | $10.09M | $4.01M |
| Cost of Revenue | $43.79M | $39.24M | $21.41M | $4.60M | $3.05M |
| Gross Profit | $43.34M | $28.81M | $14.39M | $5.49M | $0.96M |
| Gross Margin %(computed) | 49.75% | 42.33% | 40.20% | 54.37% | 24.01% |
| Operating Expenses | |||||
| R&D Expenses | $10.52M | $9.52M | $4.72M | $3.17M | $2.80M |
| G&A Expenses | $46.06M | $34.21M | $20.37M | $8.69M | $4.93M |
| Total Operating Expenses | $69.31M | $55.43M | $34.52M | $17.24M | $10.66M |
| Operating Income | ($25.97M) | ($26.62M) | ($20.13M) | ($11.76M) | ($9.69M) |
| Operating Margin %(computed) | -29.81% | -39.12% | -56.22% | -116.54% | -241.54% |
| Interest Income | $1.23M | $0.75M | $0.30M | $0.16M | $0.00M |
| Interest Expense | $0.11M | $0.20M | $0.50M | $0.24M | $0.39M |
| Income Before Tax | ($26.42M) | ($251.67M) | ($20.46M) | ($12.04M) | ($10.08M) |
| Income Tax Expense | ($0.47M) | ($0.32M) | ($0.23M) | $0.00M | ($0.00M) |
| Net Income | ($25.95M) | ($251.35M) | ($20.23M) | ($12.04M) | ($10.08M) |
| Net Margin %(computed) | -29.79% | -369.37% | -56.51% | -119.37% | -251.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.39 | $-4.48 | $-0.31 | $-0.19 | $-0.16 |
| Wtd Avg Shares | 66.14M | 56.11M | 64.88M | 64.88M | 64.88M |
| EBITDA | ($21.31M) | ($249.21M) | ($17.32M) | ($10.93M) | ($9.56M) |
| EBITDA Margin %(computed) | -24.46% | -366.22% | -48.39% | -108.32% | -238.20% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Dialogue Health Technologies Inc. data
About Dialogue Health Technologies Inc. (DLHTF) Income Statement
Dialogue Health Technologies Inc. (DLHTF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, DLHTF reported revenue of $0.09B, gross profit of $0.04B (gross margin 49.75%), and net income of ($0.03B) — a net profit margin of -29.79%.
Frequently asked questions
DLHTF · 4 questionsDialogue Health Technologies Inc. (DLHTF) reported revenue of $0.09B for 2022, up 28.0% year-over-year.
DLHTF revenueDLHTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09